Key Insights

Highlights

Success Rate

89% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

6.8%

3 terminated out of 44 trials

Success Rate

88.9%

+2.4% vs benchmark

Late-Stage Pipeline

9%

4 trials in Phase 3/4

Results Transparency

21%

5 of 24 completed with results

Key Signals

5 with results89% success

Data Visualizations

Phase Distribution

31Total
Not Applicable (11)
Early P 1 (1)
P 1 (5)
P 2 (10)
P 3 (4)

Trial Status

Completed24
Recruiting7
Unknown4
Terminated3
Active Not Recruiting3
Withdrawn2

Trial Success Rate

88.9%

Benchmark: 86.5%

Based on 24 completed trials

Clinical Trials (44)

Showing 20 of 20 trials
NCT06706401Phase 3Recruiting

Lymphocyte-Sparing And Radio-Immunotherapy in Head and Neck Carcinoma

NCT05561920CompletedPrimary

Phonatory Movement of the Pharyngoesophageal Mucosa in Laryngectomy Patients

NCT03174275Phase 2Active Not Recruiting

Carboplatin, Nab-Paclitaxel, Durvalumab Before Surgery and Adjuvant Therapy in Head and Neck Squamous Cell Carcinoma

NCT07063212Phase 2Recruiting

A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC)

NCT04368702Not ApplicableRecruiting

CONFIRM: Magnetic Resonance Guided Radiation Therapy

NCT03082534Phase 2Completed

Pembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma

NCT05793151Not ApplicableRecruiting

Multi-Site Trial of Navigation vs Treatment as Usual to Improve Initiation of Timely Adjuvant Therapy

NCT05798780Not ApplicableActive Not Recruiting

The ENHANCE Study: Exercise and Nutrition in Head And Neck CancEr Survivors

NCT07254962Phase 2Not Yet Recruiting

CApecitabine Prior to TUmor Resection in Ent Oncology (CAPTURE)

NCT06129487Not ApplicableCompleted

Evaluations of Alcohol Warning Labels

NCT02586207Phase 1Completed

Pembrolizumab in Combination With CRT for LA-SCCHN

NCT04057209Not ApplicableRecruiting

VoiceS: Voice Quality After Transoral CO2-Laser Surgery Versus Single Vocal Cord Irradiation for Larynx Cancer

NCT05497947Completed

Evaluation of the French Translation of Swallowing (SOAL-VF) Patient Reported Outcomes (PRO) After Total PharyngoLaryngectomy

NCT05337631Recruiting

Special Care Patterns for Elderly HNSCC Patients Undergoing Radiotherapy

NCT03759431Phase 2Active Not Recruiting

Vocal-cord vs. Complete Laryngeal Radiotherapy for Early Glottic Cancer

NCT04028479Completed

The Registry of Oncology Outcomes Associated with Testing and Treatment

NCT03028766Phase 1Completed

WEE1 Inhibitor with Cisplatin and Radiotherapy: a Trial in Head and Neck Cancer

NCT05471401Not ApplicableWithdrawn

GI Organ Tracking Via Balloon Applicators

NCT03653039Not ApplicableCompleted

Comparison Between a Standard Tube and the Ultra-thin Tritube for Intubation of the Trachea and for Maintaining Access to the Trachea After Anaesthesia, in Patients With an Expected Difficult Direct Laryngoscopy

NCT04892875Phase 1Withdrawn

A Study of Concurrent Chemoradiation in Combination With or Without PD1 Inhibitor AB122 Adenosine 2a Receptor / Adenosine 2b Receptor Inhibitor AB928 Therapies in Locally Advanced Head and Neck Cancers

Scroll to load more

Research Network

Activity Timeline